REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Antigen, Epitope, Or Other Immunospecific Immunoeffector (e.g., Immunospecific Vaccine, Immunospecific Stimulator Of Cell-mediated Immunity, Immunospecific Tolerogen, Immunospecific Immunosuppressor, Etc.) > Virus Or Component Thereof > Orthomyxoviridae (e.g., Influenza Virus, Fowl Plague Virus, Etc.) Orthomyxoviridae (e.g., Influenza Virus, Fowl Plague Virus, Etc.)Orthomyxoviridae (e.g., Influenza Virus, Fowl Plague Virus, Etc.) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.07/26/07 - 20070172494 - Cold-adapted equine influenza viruses The present invention provides experimentally-generated cold-adapted equine influenza viruses, and reassortant influenza A viruses comprising at least one genome segment of such an equine influenza virus, wherein the equine influenza virus genome segment confers at least one identifying phenotype of the cold-adapted equine influenza virus, such as cold-adaptation, temperature sensitivity, ... 07/12/07 - 20070160631 - Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes The present invention provides synthetic immunogenic lipopeptide molecules comprising co-linear T-helper and CTL epitopes, and methods for their production and use in the generation of primary and secondary immune responses, and for the vaccination of animal subjects against particular CTL epitopes. More particularly, the present invention provides highly soluble lipopeptides ... 06/14/07 - 20070134271 - Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines Chimeric human-bovine parainfluenza viruses (PIVs) are infectious and attenuated in humans and other mammals and useful individually or in combination in vaccine formulations for eliciting an anti-PIV immune response. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigenome which includes a partial or complete ... 06/14/07 - 20070134270 - Chicken rna polymerase i promoter and the use thereof The invention relates to a novel polynucleotide exhibiting a promoting transcription activity, polynucleotide-containing vectors and to the use thereof for the transcription of interesting sequences such as the production of non-cap RNA virus. Said invention also relates to host cells preferably of avian origin, containing a polynucleotide or the inventive ... 06/07/07 - 20070128223 - Cd40 ligand fusion protein vaccine Provided are methods of generating an immune response to any of various antigens including foreign antigens such as infectious agent antigens. In general, the method comprises administering an expression vector encoding a transcription unit encoding a secretable fusion protein, the fusion protein containing the foreign antigen and CD40 ligand and ... 06/07/07 - 20070128222 - Fusogenic, self-propagating blebs as immunogenic compositions Self-propagating, fusogenic blebs are produced from cells infected with a population of Venezuelan Equine Encephalitis virus replicon particles (VRP). The self-propagating, fusogenic nature of the blebs is derived from expression of heterologous genes encoding viral fusion proteins that are incorporated into the replication defective replicon particles. The resulting blebs can ... 05/03/07 - 20070098742 - Canine influenza virus and related compositions and methods of use The present invention provides an isolated canine influenza virus of subtype H3N8 comprising an HA having SEQ ID NO: 4 or an amino acid sequence that is greater than 99% identical to SEQ ID NO: 4, with the proviso that the amino acids at positions 94 and 233 are identical ... 04/26/07 - 20070092537 - Compositions and methods for the treatment of canine influenza virus disease Compositions, including vaccine compositions, and methods for treating, preventing or ameliorating canine influenza virus (CIV) disease by utilizing one or more canine influenza virus (CIV) or equine influenza virus (EIV) strain or immunogens thereof are set forth herein. Also set forth are challenge models useful in assessing the efficacy of ... 04/26/07 - 20070092536 - Cold-adapted equine influenza viruses The present invention provides experimentally-generated cold-adapted equine influenza viruses, and reassortant influenza A viruses comprising at least one genome segment of such an equine influenza virus, wherein the equine influenza virus genome segment confers at least one identifying phenotype of the cold-adapted equine influenza virus, such as cold-adaptation, temperature sensitivity, ... 04/12/07 - 20070082012 - Vaccines and methods to treat canine influenza The present invention relates to providing new vaccines and treatments for the diseases related to canine influenza virus. It discloses influenza viral antigens, and methods of presenting these antigens to canines, especially dogs. It relates to attenuated and killed vaccines. The present invention relates to experimentally generated canine and equine ... 04/05/07 - 20070077258 - Administration of glutathione (reduced) via intravenous or encapsulated in liposome for the amelioration of tnf-alpha effects and flu-like viral symptoms and treatment and prevention of virus The invention is a method of treatment of the symptoms related to inflammation that accompanies the release of Tumor Necrosis Factor-alpha in diseases such as viral infection such as those affecting the respiratory tract by providing systemic glutathione (reduced) by oral administration of glutathione (reduced) in a liposome encapsulation or ... 02/22/07 - 20070042002 - Influenza recombinant subunit vaccine The invention provides influenza proteins, including subunit proteins and immunogenic compositions that can be utilized, with or without adjuvants, as vaccines to protect against influenza infection in animal models and humans. The recombinant proteins are expressed from transformed insect cells that contain integrated copies of the appropriate expression cassettes in ... 02/22/07 - 20070042001 - Influenza recombinant subunit vaccine The invention provides influenza proteins, including subunit proteins and immunogenic compositions that can be utilized, with or without adjuvants, as vaccines to protect against influenza infection in animal models and humans. The recombinant proteins are expressed from transformed insect cells that contain integrated copies of the appropriate expression cassettes in ... 02/08/07 - 20070031453 - Modified influenza virus for monitoring and improving vaccine efficiency The immunogenicity of the influenza virus hemagglutinin (HA) molecule may be increased by substitutions of amino acids in the HA sequence. The substitution of specific HA residues, such as asparagine at position 223 of H5 HA, increase the sensitivity of the hemagglutinin inhibition (HI) assay by altering receptor specificity and/or ... 01/04/07 - 20070003576 - Vaccines for the rapid response to pandemic avian influenza The present invention relates to adenovirus-based vaccines against avian influenza viruses with pandemic potential. The present invention provides replication-defective adenoviral vectors, each having a nucleic acid encoding an influenza A polypeptide. When introduced into a subject, the expressed influenza A polypeptide induces the production of antibodies that bind to influenza. ... 11/02/06 - 20060246092 - Immunoprotective influenza antigen and its use in vaccination The present invention relates to an influenza antigen, comprising a fusion product of at least the extracellular part of a conserved influenza membrane protein or a functional fragment thereof and a presenting carrier, which may be a presenting (poly)peptide or a non-peptidic structure, such as glycans, peptide mimetics, synthetic polymers. ... 10/12/06 - 20060228376 - Virosome-like-particles The invention relates to the production of virosome-like-particles. The invention provides a method for producing a virosome-like-particle comprising contacting an enveloped virus with a solution containing a short-chain phospholipid allowing solubilisation of the viral envelope of said virus further comprising removing short-chain phospholipid from said solution allowing formation of a ... 08/10/06 - 20060177468 - Delivery vehicles, bioactive substances and viral vaccines The invention relates to compositions and methods for the safe delivery of a bioactive agent to an animal. Preferably, the bioactive agent is a vaccine, and more preferably, the bioactive agent is a virus. ... 08/03/06 - 20060171961 - Composition and method for preventing or treating a virus infection The present invention provides multiple antigenic agents compositions and the use thereof to prevent or treat viral infections. ... 07/13/06 - 20060153872 - Methods of producing influenza vaccine compositions Methods and compositions for the optimization and production of influenza viruses, e.g., ca influenza B strains, in eggs and host cells suitable as influenza vaccines are provided. ... 07/13/06 - 20060153871 - H3 equine influenza a virus The invention provides an isolated H3 equine influenza A virus, as well as methods of preparing and using the virus, and genes or proteins thereof. ... 06/22/06 - 20060134138 - Recombinant influenza viruses for vaccines and gene therapy The invention provides a composition useful to prepare influenza A viruses, e.g., in the absence of helper virus. ... 06/08/06 - 20060121055 - Compositions with enhanced immunogenicity The present invention relates to immunogenic compositions containing an immunogen and a specific combination of two or more traditional excipients. The excipients in the composition act in combination and enhance immune responses to the immunogen from a subject. The combination of excipients may be used as adjuvant in immunogenic compositions, ... 05/25/06 - 20060110406 - Refrigerator-temperature stable influenza vaccine compositions Methods and compositions for the optimization and production of refrigerator-temperature stable virus, e.g., influenza, compositions are provided. Formulations and immunogenic compositions comprising refrigerator-temperature stable virus compositions are provided. ... 01/05/06 - 20060002959 - Skin-sctive adjuvants for transcutaneous immuization Transcutaneous immunization can deliver antigen to the immune system through the stratum corneum without physical or chemical penetration to the dermis layer of the skin. This delivery system induces an antigen-specific immune response. Use of skin-active adjuvants is preferred. Although perforation of intact skin is not required, superficial penetration or ... 01/05/06 - 20060002958 - Attenuation of metapneumovirus The present invention relates to a vaccine against members of the genus metapneumovirus or RSV or a virus that comprises a significant genetic homology in the F protein to members of the genus metapneumovirus, whereby the vaccine is an attenuated live vaccine. In particular, the vaccine is directed against metapneumovirus ... 12/01/05 - 20050266026 - Multi plasmid system for the production of influenza virus Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided. Additionally, the invention provides methods of producing influenza viruses with enhanced ability to replicate in embryonated chicken ... 10/20/05 - 20050232950 - Viruses comprising mutant ion channel protein A method to prepare viruses lacking ion channel activity is provided. ... 09/15/05 - 20050202044 - Immune responses using compositions containing stress proteins The present invention relates to a vaccine for inducing an immune response to an antigen in a vertebrate (e.g., mammal) comprising an antigen and all or a portion of a stress protein or all or a portion of a protein having an amino acid sequence sufficiently homologous to the amino ... 09/08/05 - 20050196413 - Inactivated influenza virus vaccine for nasal or oral application The invention relates to nasal or oral administration of a compound containing inactivated influenza virus antigen and aluminum as adjuvant for the prophylaxis of influenza virus infections. Said vaccine is especially suitable for inducing a mucosal IgA immune response and systemic IgG immune response. ... 08/25/05 - 20050186223 - Virus production An improved process for recovery of virus from allantoic fluid of virus-infected chick embryos. Virus associated with granular and fibrous debris in the allantoic fluid can be disassociated from the debris and recovered, thereby increasing viral yield. Dissociation can be achieved by subjecting the virus-debris complex to conditions of increased ... 07/21/05 - 20050158342 - Multi plasmid system for the production of influenza virus Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided. Additionally, the invention provides methods of producing influenza viruses with enhanced ability to replicate in embryonated chicken ... 07/14/05 - 20050152918 - Methods and apparatus for harvesting vaccine from eggs Methods and apparatus for producing vaccine within a plurality of eggs are provided. Each of a plurality of eggs is illuminated with light from one or more LEDs. A detector is positioned adjacent each egg and detects light passing therethrough. Each egg is then identified as containing a live embryo ... ### FreshPatents.com Support |